A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma.
Xiong M, Liu R, Lei X, Fan D, Lin F, Hao W, Yuan X, Yang Y, Zhang X, Ye Z, Lu Y, Zhang Y, Wang J, Xiong D.
Xiong M, et al. Among authors: ye z.
J Immunother. 2022 Feb-Mar 01;45(2):78-88. doi: 10.1097/CJI.0000000000000401.
J Immunother. 2022.
PMID: 34711791